Compare Abbott Laboratories (ABT) vs Digital Realty Trust, Inc. (DLR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Digital Realty Trust, Inc. — how do they compare? Abbott Laboratories trades at $95.6 (market cap $166.94B), while Digital Realty Trust, Inc. trades at $174.96 (market cap $64.71B). The key difference: Abbott Laboratories is far larger — about 2.6× Digital Realty Trust, Inc.'s market cap, and Digital Realty Trust, Inc. pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| ABT | DLR | |
|---|---|---|
Market Cap | $166.94B | $64.71B |
Sector | Health | Real Estate |
52-Week High | $136.62 | $203.91 |
52-Week Low | $82.57 | $147.93 |
Enterprise Value | $193.69B | $82.23B |
Dividend Yield | 2.63% | 2.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
DLR trades at $174.9, up 0.92% today, with a bearish technical signal but strong analyst buy consensus. The stock shows robust revenue growth, with 2025 revenue at $6.11B and net income margin of 21.73%, though valuation ratios like P/E of 46.07 appear elevated. Recent news highlights a $7.8B data center acquisition from Blackstone, expanding its hyperscale portfolio amid AI-driven demand.
Outlook remains positive with a consensus price target of $219.08, but risks include high debt levels, execution challenges from recent acquisitions, and competitive pressures. The stock offers growth exposure to data center infrastructure, supported by institutional confidence, yet investors should weigh valuation concerns against expansion potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Digital Realty Trust, Inc.
Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →
